Dallas, Texas, Oct. 20, 2022 (GLOBE NEWSWIRE) -- The global ileostomy market is expected to be driven by the rising prevalence of serious chronic conditions including cancer and Crohn's disease, as well as consumer awareness and technological improvements such as stoma bag sensor devices that alert patients and doctors about stoma bag volume. During the forecast period, new products, services, and device development, multinational companies' investments in developing economies, an increase in the number of cancer patients, and technological advancements in ileostomy drainage bags that favorably affect patients' comfort and affordability are anticipated to drive the market. The global ileostomy market will expand at a CAGR of 4.4% and grow from US$ 578.3 million in 2021 to US$ 890.2 billion by 2030, with much of this attributed to customers' growing trust in ostomy treatment.
For Right Perspective and Competitive Insights, Get Sample Report @ https://www.adroitmarketresearch.com/contacts/request-sample/3564
The ileostomy market care is being driven by a number of important factors, including an increasing geriatric population, an increase in patients with colorectal cancer and defective bladders, an increase in the number of ileostomy surgeries on the bowel, and an increase in the number of awareness programmes to educate patients about the use of ileostomy products. Additionally, growing internet usage for online ileostomy product sales and growing medical travel to Asian nations will all lead to new prospects for the global ileostomy industry throughout the anticipated timeframe. Large intestine problems that are challenging to treat with conventional drugs can be treated surgically with an ileostomy. The most prevalent reason for an ileostomy is inflammatory bowel disease, which is caused by an inconsistent functioning of the large intestine in throwing out waste.
As the most popular and often performed surgery, the end ileostomy segment commands a sizeable market share and is thought to be patients' top choice because of its lower risk of complications, decreased risk of wound infection, and lower overall cost.
The end ileostomy segment is predicted to grow rapidly over the course of the projection period. The fact that it avoids post-surgical infections and requires less supportive care than loop ileostomy is credited with driving the segment's growth. Additionally, loop ileostomy is favored by researchers everywhere in the world.
Report coverage & details:
| Report Coverage | Details |
| CAGR | CAGR of 4.4% during 2022-2030 |
| Segment Covered | Procedure Type, Equipment Type , End-user, Regions |
| Procedure Type | Loop Ileostomy, End Ileostomy |
| Equipment Type | Belts & Girdles, Stoma Bags, Stoma Guards, Adhesive Sprays |
| End User | Research Institutes, Hospitals, Ambulatory Surgical Center |
| Regions Covered | North America, Europe, Asia Pacific, Middle East and Africa, South America |
| Key Players Profiled | Salts Healthcare, Alcare Co., 3M Healthcare, B. Braun Melsungen AG, Hollister Incorporated, Coloplast Corp |
Enquire before purchasing this report at: https://www.adroitmarketresearch.com/contacts/enquiry-before-buying/3564
Geographically, Europe led the world market in 2021 with a share of more than 40%. The area has a highly developed healthcare system, which has helped the European ileostomy market grow. In addition, a number of top corporations with headquarters across Europe profit from the hospitable healthcare regulations in the continent. These characteristics are projected to keep Europe as a lucrative ileostomy industry. During the course of the forecast year, it is expected that Asia Pacific would perform better than western countries in terms of CAGR. Due to its healthcare policies and funding for cancer treatments, North America also holds a sizable portion of the market over the forecast period.
Numerous charitable groups and private players are stepping forward to create global awareness about ostomy treatment. Furthermore, the European Ostomy Association recognizes World Ostomy Day every year to dispel ileostomy fallacies and encourage patients to undergo the procedure. The ileum, as well as the large intestine and other parts of the digestive tract, are affected by Crohn's disease. An ileostomy is performed for a variety of conditions, including Hirschprung's illness, colon cancer, and birth abnormalities.
Table of Contents:
1. Introduction
2. Research Methodology
3. Market Outlook
4. Ileostomy Products Market by Procedure Type, 2021-2030 (USD Billion)
5. Ileostomy Products Market by End User, 2021-2030 (USD Billion)
6. Ileostomy Products Market by Region, 2021-2030 (USD Billion)
7. Competitive Landscape
8. Company Profile
9. Appendix
To purchase research report: https://www.adroitmarketresearch.com/researchreport/purchase/3564
Access research repository of Upcoming Reports @ https://adroitmarketresearch.com/upcoming.html
About Us:
Adroit Market Research is an India-based business analytics and consulting company incorporated in 2018. Our target audience is a wide range of corporations, manufacturing companies, product/technology development institutions and industry associations that require understanding of a market’s size, key trends, participants and future outlook of an industry. We intend to become our clients’ knowledge partner and provide them with valuable market insights to help create opportunities that increase their revenues. We follow a code– Explore, Learn and Transform. At our core, we are curious people who love to identify and understand industry patterns, create an insightful study around our findings and churn out money-making roadmaps.
Contact Us:
Ryan Johnson
Account Manager - Global
3131 McKinney Ave Ste 600
Dallas, TX 75204
Email ID: sales@adroitmarketresearch.com
Phone No.: +1-9726644514, +91-9665341414
Connect with us: Facebook | Twitter | LinkedIn
